Skip to content

4Accepted Oct 5, 8:42 PM ET

Dolby Laboratories: svp, entertainment John D Couling exercised 7,667 shares

DLBDolby Laboratories, Inc.

Accepted (ET)

8:42 PM

Oct 5, 2026

Filed

Oct 5, 2026

Documents

1

Size

11.0 KB

Summary

Dolby Laboratories: svp, entertainment John D Couling exercised 7,667 shares

Updated

What happened

  • John D Couling, svp, entertainment, exercised options to acquire 7,667 shares at $45.50 per share for $348,849 on Oct 1, 2026, and sold 7,667 shares the same date in open-market transactions for a total of $450,690. The Form 4 also reports the derivative disposition of 7,667 shares at $0.00.

Key details

  • Transaction date: Oct 1, 2026.
  • Exercise: 7,667 shares at $45.50 each, total $348,849 (code M).
  • Sales: 6,831 shares at a weighted average price of $58.72, total $401,092 (code S); 836 shares at a weighted average price of $59.33, total $49,598 (code S).
  • Footnotes: sales reported with price ranges — $58.275 to $59.255 (F2) and $59.32 to $59.41 (F3); reporting person can provide detailed share-by-price info on request. Footnote F4 states the option exercised was part of a 46,000-share grant and was fully vested and exercisable as of the transaction date. Footnote F1 notes shares held following the transactions include 103,190 shares underlying restricted stock units that are subject to forfeiture until they vest.
  • Form 4 filed Oct 5, 2026, reporting transactions dated Oct 1, 2026.

Why it may matter

  • The filing shows an option exercise and same-day sales of the resulting shares, consistent with a cashless exercise (exercise followed by open-market sales).
  • The exercised option was fully vested and part of a larger 46,000-share grant.
  • This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing